Loading company…
Israeli medical device company, founded in 2009, developing non-implant valve treatments for structural heart disease.
Pi-Cardia designs and manufactures catheter-based medical devices for structural heart disease, focused on non-implant valve treatments. Its ShortCut device is FDA-cleared for splitting valve leaflets, while the Leaflex Performer remains investigational. Founded in 2009 and headquartered in Rehovot, Israel, the company is listed at Series C stage. In July 2020, it raised USD 25 mn, primarily from Venus MedTech (HangZhou) Inc., and Erez Golan is CEO and co-founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in